mHealth Intelligence September 18, 2020
A new Health Affairs blog urges the federal government to continue telehealth waivers for substance abuse treatment during the COVID-19 emergency and asks for permanent changes to safeguards around the use of buprenorphine.
A group of clinicians and public health experts is pressing the federal government to make permanent telehealth policy changes that would improve access to care for people undergoing substance abuse treatment.
In a recent blog in Health Affairs, the Buprenorphine Telehealth Consortium is urging the Health and Human Services Secretary to waive a requirement in the Ryan Haight Act that mandates an in-person exam for emergency treatment during the ongoing coronavirus pandemic. This would allow providers to use telehealth to determine whether a patient undergoing treatment for...